| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $88,983,247 ) (Continued on the next page) |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R21AI193971 | Multi-Ancestry Genome-wide Association Analysis and Polygenic Risk Score of Moderate-to-Severe Asthma | 000 | 1 | NIH | 7/23/2025 | $458,634 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01DK142998 | Feasibility, Acceptability, and Preliminary Phase II Efficacy Testing of a Community-Informed Infant Obesity Prevention Program Addressing the Impact of Maternal Mental Health on Eating and Feeding | 000 | 1 | NIH | 8/22/2025 | $337,906 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | 005 | 26 | NIH | 7/30/2025 | $723,623 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | 003 | 26 | NIH | 7/9/2025 | $0 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | 003 | 26 | NIH | 7/9/2025 | $0 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | 004 | 26 | NIH | 7/22/2025 | $0 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | 004 | 26 | NIH | 7/22/2025 | $0 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R35GM149538 | Novel regulators of macrophage function to repair sterile inflammation-induced heart injury | 002 | 3 | NIH | 8/5/2025 | $44,519 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS137887 | No REST for 5-HT Neurons Following Traumatic Brain Injury | 000 | 2 | NIH | 8/8/2025 | $405,000 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | 001 | 26 | NIH | 2/25/2025 | $0 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R35GM149538 | Novel regulators of macrophage function to repair sterile inflammation-induced heart injury | 001 | 3 | NIH | 3/21/2025 | $400,672 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | 001 | 26 | NIH | 2/25/2025 | $0 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | 002 | 26 | NIH | 3/20/2025 | $0 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | 002 | 26 | NIH | 3/20/2025 | $0 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | 000 | 26 | NIH | 1/17/2025 | $848,076 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | 000 | 26 | NIH | 1/17/2025 | $6,951,611 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | 006 | 26 | NIH | 7/30/2025 | $723,623 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | 005 | 26 | NIH | 7/30/2025 | $0 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R21HL172156 | Patient centered outcome measures and prediction tools in lymphangioleiomyomatosis | 000 | 2 | NIH | 1/14/2025 | $123,917 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01DK106364 | On the regulation of hepatic glucose metabolism during insulin-induced hypoglycemia | 001 | 9 | NIH | 7/10/2025 | $61,943 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01DK106364 | On the regulation of hepatic glucose metabolism during insulin-induced hypoglycemia | 000 | 9 | NIH | 1/8/2025 | $557,488 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01HL168464 | A novel strategy for heart failure therapeutics | 001 | 2 | NIH | 8/19/2025 | $53,492 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS121426 | Monitoring rapid guanosine signaling during ischemia | 000 | 5 | NIH | 1/28/2025 | $350,086 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01HL168464 | A novel strategy for heart failure therapeutics | 000 | 2 | NIH | 11/8/2024 | $481,436 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01EB035594 | Designing a deployable and adaptable plasmonic sensing platform for infectious disease surveillance | 000 | 2 | NIH | 4/15/2025 | $326,891 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R37CA272854 | Investigating the molecular mechanisms of growth in GNAS mutant pancreatic cancer. | 000 | 4 | NIH | 8/15/2025 | $370,575 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R35GM151170 | Molecular regulation of the CRAC channel signaling pathway | 000 | 3 | NIH | 4/29/2025 | $405,000 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R03NS144870 | Role of NK cell subsets in an animal model of relapsing-remittingmultiple sclerosis | 000 | 1 | NIH | 7/30/2025 | $81,000 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R37NS122141 | Neuromodulatory regulation of synaptic plasticity in spinal nociceptive circuits | 000 | 4 | NIH | 3/19/2025 | $536,380 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | K23DC022306 | Adapting ECHO for Autistic Children's Communication | 000 | 1 | NIH | 7/25/2025 | $191,268 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | K23HL164971 | Biomarker Discovery in Portopulmonary Hypertension | 000 | 3 | NIH | 2/27/2025 | $204,228 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01HL176858 | Elucidating the Sexual Cycle of HIV/AIDS-Related Pneumocystis Pneumonia | 000 | 1 | NIH | 7/29/2025 | $508,041 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | F31HL175976 | The Role of Platelet-Derived Transforming Growth Factor Beta in Abdominal Aortic Aneurysm | 000 | 2 | NIH | 8/13/2025 | $49,524 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R21AG085052 | The cell-specific neurodegenerative potential of mitochondria post-traumatic brain injury | 000 | 2 | NIH | 7/28/2025 | $239,172 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | F31HL176101 | The Role of c-ABL in Mediating TIE2 Signaling and Formation of Venous Malformation | 000 | 2 | NIH | 8/14/2025 | $46,950 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01CA279962 | Genetically-encoded molecular imaging of genome-edited immune cells | 000 | 2 | NIH | 8/18/2025 | $459,409 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS119827 | Regulation of Angpt1 and DIPG blood-brain barrier integrity by H3K27M mutations | 000 | 4 | NIH | 11/19/2024 | $367,240 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01CA259845 | Fatty acid metabolism regulates ferroptosis in mutant KRAS lung cancer | 001 | 4 | NIH | 6/18/2025 | $40,203 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01CA259845 | Fatty acid metabolism regulates ferroptosis in mutant KRAS lung cancer | 000 | 4 | NIH | 12/16/2024 | $361,832 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | F31HL172649 | Pathophysiological impact of subtypes of eosinophil cell death | 000 | 2 | NIH | 8/18/2025 | $46,950 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS134804 | Developing multi-cue piezoelectric PVDF-TrFE biomaterials for peripheral nerve repair | 000 | 2 | NIH | 12/19/2024 | $410,896 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01HL156954 | Polymorphic ApoE at the crossroad of lipid metabolism and inflammation in atherosclerosis | 001 | 4 | NIH | 8/5/2025 | $61,494 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01HL170100 | Defining Relationships of Early Mediators and Moderators of Sleep (DREAMS) | 000 | 2 | NIH | 8/22/2025 | $702,569 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01HL156954 | Polymorphic ApoE at the crossroad of lipid metabolism and inflammation in atherosclerosis | 000 | 4 | NIH | 11/20/2024 | $553,447 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | T32GM149200 | Medical Scientist Training Program | 000 | 3 | NIH | 8/1/2025 | $1,050,811 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01MH133070 | Airway inflammation and fear: elucidating immune mediators and neural substrates | 000 | 2 | NIH | 6/18/2025 | $612,853 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01GM156796 | Fundamental properties of circadian rhythms | 000 | 1 | NIH | 9/9/2025 | $380,089 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R00AR083486 | Novel models to study dorsal root ganglion neurons in knee osteoarthritis pain | 000 | 2 | NIH | 9/11/2025 | $249,000 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01HL178848 | Dysregulation of sphingolipid metabolism and signaling in LAM | 000 | 1 | NIH | 9/3/2025 | $728,776 |
|
